|Last Price$0.33||Day Change (%)%|
|Open Price$0.33||Day Change ($)|
|Day Range0.33–0.33||52-Week Range0.32–1.00|
IMS Health Chairman & CEO Ari Bousbib to Speak at J.P. Morgan 33rd Annual Healthcare Conference on January 13
Mylan Launches Generic Diovan® Tablets
CORRECTING and REPLACING Recent Global Survey from Vicks® Suggests Busy Consumers Are Reluctant to Take a Sick Day
Hikma to Launch Colchicine 0.6mg Capsules
HITRUST Updates Common Security Framework to Include Privacy Controls
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.